Le Lézard
Classified in: Environment, Health, Sports and recreation
Subjects: NPT, CHI, CSR, ENI, FVT

Life Time Foundation Investing in Local Community Impact During Miami Marathon Weekend January 27-28


Beach Clean Up, Kids Run, Foundation Athlete Fundraising and Support of Miami-Dade Schools Among Planned Efforts

CHANHASSEN, Minn., Jan. 12, 2024 /PRNewswire/ -- The Life Time Foundation, a 501(c)(3) nonprofit created by Life Time Inc. (NYSE: LTH), is committed to supporting initiatives that inspire Healthy People, a Healthy Planet, and a Healthy Way of Life.

During the Life Time Miami Marathon And Half weekend (January 27-28), the Life Time Foundation is leading efforts to enhance the local community. Initiatives include:

For more information or to support the Life Time Foundation's cause, visit here.

The Miami Marathon is owned and produced by Life Time, the premier healthy lifestyle brand. It is among more than 30 premier athletic events operated by the company, including the Chicago Half Marathon, Garmin UNBOUND Gravel, and the Leadville Race Series. To view and learn more about Life Time athletic events, visit: lifetime.life/athletic-events.

About Life Time Foundation

The Life Time Foundation, a 501c(3) nonprofit created by Life Time, Inc. is dedicated to inspiring Healthy People, a Healthy Planet, and a Healthy Way of Life. Through financial grants and direct action, we support Youth Nutrition by helping schools serve wholesome, nourishing, minimally processed food to students; Youth Movement by championing physical movement programs that get children active and excited to move for life; and a Healthy Planet by supporting forestation and conservation initiatives, so everyone can live healthy, happy lives. For more information, visit www.ltfoundation.org.

SOURCE Life Time Foundation


These press releases may also interest you

at 21:29
BlueHuki, a premier digital marketing firm led by Dr. Heather Pressler, is proud to announce the acceptance of a chapter, titled "Social Media in Healthcare: Guide for Leadership and Strategies," for publication in the forthcoming book, "New Horizons...

at 21:27
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced today that it has entered into a multi-target antibody discovery collaboration with Umoja Biopharma, a transformative immunotherapy...

at 20:33
On one hand, Takanori Takebe, MD, PhD, would prefer to be remembered for his multiple breakthrough contributions to organoid medicine. However, he may never be forgotten for his work to demonstrate that people can "breathe"...

at 20:00
Halozyme Therapeutics, Inc. ("Halozyme") today announced that Roche received U.S. Food and Drug Administration (FDA) approval for Tecentriq Hybrezatm (atezolizumab and hyaluronidase-tqjs) with Halozyme's ENHANZE® drug delivery technology. Tecentriq...

at 19:35
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq Hybrezatm (atezolizumab and hyaluronidase-tqjs), the first and only PD-(L)1 inhibitor for...

at 19:30
Bio-Me AS Announces Appointment of Arne Materna as Co-CEO alongside Dr. Warren Flood Dr. Arne Materna has been appointed Co-CEO as of July 1st, 2024 to strengthen the company's capitalization and continued commercial growth.Bio-Me reports strong...



News published on and distributed by: